SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
657.00    5.00 (0.77%)
Bid:
657.00
Ask:
660.00
Spread: 3.00 (0.457%)
Market Cap: £534.77m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Trading Statement

13 Jan 2011 07:00

RNS Number : 3815Z
Bloomsbury Publishing PLC
13 January 2011
 



 

 

 

 

 

13 January 2011

 

 

 

Bloomsbury Publishing Plc

("Bloomsbury" or "the Group")

Trading Statement

 

 

Bloomsbury Publishing today announces its trading update for the twelve month period ending 31 December 2010 and reports that 2010 trading was in line with management's expectations.

2010 book sales were excellent, driven by revenues from a broad range of titles across our UK, US and German businesses. Sales in the final quarter proved resilient despite the adverse weather conditions. In the UK, The Man Booker Prize winner, The Finkler Question by Howard Jacobson, Operation Mincemeat by Ben Macintyre, the film tie-in edition of Eat, Pray, Love by Elizabeth Gilbert and The Flavour Thesaurus by Niki Segnit were amongst our top selling new titles. Books published in prior years continued to be in demand, led by River Cottage Everyday by Hugh Fearnley-Whittingstall and the seven Harry Potter books, which sold well on the back of the film Harry Potter and the Deathly Hallows Part 1 and the release of the series with new jacket designs.

In the US, we also published The Finkler Question and this continued to be one of our top sellers in the run-up to Christmas and reached the New York Times bestseller list. In addition, Entice by Carrie Jones and Deadly Spin by Wendell Potter were strong sellers. In Germany, the second half of the year had a stronger publishing programme. Eat, Pray, Love performed well and Berthold Beitz: Die Biographie by Joachim Käppner was also a bestseller.

E-book revenues gathered momentum in 2010 and in some cases made up a sizable percentage of sales by value of some of our bestsellers. With the increase in the number of e-readers and other platforms sold into the market, we expect e-book revenue growth to continue. 

We have received a positive response to database projects and management contract proposals and are in discussion with third parties about these. Our strategic investment in academic and professional publishing is progressing well with Public Library Online, Bloomsbury Academic, Methuen Drama, the Arden Shakespeare and the online Berg Fashion Library, which with the The Oxford University Press Encyclopedia of World Dress and Fashion, was awarded the 2011 Dartmouth Medal for its extensive and outstanding multidisciplinary coverage of dress, fashion and its impact on society. Bloomsbury Qatar Foundation Journals was launched by Qatar Foundation in November where we are supplying publishing services. In other specialist areas A&C Black showed solid sales particularly with Alexander McQueen: Genius of a Generation.

Period-end cash for the Group is likely to be in the region of £34.2m.

The results for the twelve month period ended 31st December 2010 will be announced on 28th February 2011. As a reminder the Company's year-end is moving to the end of February and, accordingly, we shall also announce results for the fourteen month period to 28 February 2011 in May.

-ends-

Enquiries:

Pelham Bell Pottinger - Dan de Belder / Rosanne Perry 020 7861 3232

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGMMNZZGMZM
Date   Source Headline
20th Mar 20257:00 amRNSTrading Update and Board Appointment
3rd Mar 20257:00 amRNSNotice of Trading Update
24th Feb 20254:27 pmRNSHolding(s) in Company
14th Feb 202510:05 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20257:00 amRNSBloomsbury reaches new agreement with Amazon
16th Dec 202410:05 amRNSHolding(s) in Company
16th Dec 20249:55 amRNSHolding(s) in Company - Replacement
11th Dec 202410:24 amRNSDirector/PDMR Shareholding
9th Dec 20249:18 amRNSDirector/PDMR Shareholding
26th Nov 202411:44 amRNSHolding(s) in Company
26th Nov 202410:35 amRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSUnaudited Interim Results
30th Sep 20247:00 amRNSNotice of Interim Results
2nd Sep 202411:31 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDirector/PDMR Shareholding
28th Aug 202410:57 amRNSDirector/PDMR Shareholding
16th Aug 20244:18 pmRNSAMENDMENT: BLOCK LISTING SIX MONTHLY RETURN
16th Aug 20249:42 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Aug 20245:36 pmRNSAwards under the 2023 Executive Share Plan
16th Jul 20243:41 pmRNSResults of the 2024 Annual General Meeting
16th Jul 20247:00 amRNSAGM Trading Update
14th Jun 20245:01 pmRNSAnnual Financial Report
14th Jun 20241:48 pmRNSBoard Appointment
29th May 20247:00 amRNSAcquisition
23rd May 20247:00 amRNSChairman Succession Announcement
23rd May 20247:00 amRNSAudited Preliminary Results
20th May 20247:00 amRNSInvestor Presentation
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.